Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

about

Implications of Measurement Assay Type in Design of HIV Experiments.

P2860

Q50042023-D5BFC260-FF67-4921-9611-3C141757396D

P2860

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

Item

http://www.wikidata.org/entity/Q47301054

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@en

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@nl

type

Item

label

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@en

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@nl

prefLabel

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@en

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

@nl

P1476

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence

@en

P2093

Cesar Augusto Vargas Garcia

http://www.w3.org/2001/XMLSchema#string

LaMont Cannon

http://www.w3.org/2001/XMLSchema#string

Michael J Piovoso

http://www.w3.org/2001/XMLSchema#string

P2860

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

Modelling HIV-1 2-LTR dynamics following raltegravir intensification.

Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

P304

1295-1300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1109/ACC.2016.7525096

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Ryan Zurakowski

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29332991

http://www.w3.org/2001/XMLSchema#string

P932

5761735

http://www.w3.org/2001/XMLSchema#string

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

about

P2860

P2860

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932